-
1دورية أكاديمية
المؤلفون: Ibiayi Dagogo-Jack, MD, Lesli A. Kiedrowski, MS, MPH, Rebecca S. Heist, MD, MPH, Jessica J. Lin, MD, Catherine B. Meador, MD, PhD, Elizabeth A. Krueger, NP, Andrew Do, BS, Jennifer Peterson, BS, Lecia V. Sequist, MD, MPH, Justin F. Gainor, MD, Jochen K. Lennerz, MD, PhD, Subba R. Digumarthy, MD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 8, Pp 100534- (2023)
مصطلحات موضوعية: ALK, MET amplification, Capmatinib, Crizotinib, Alectinib, Lorlatinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364323000735Test; https://doaj.org/toc/2666-3643Test
-
2دورية أكاديمية
المؤلفون: Ibiayi Dagogo-Jack, MD, Ivan Valiev, MD, Nikita Kotlov, MS, Anna Belozerova, MD, Aleksandra Lopareva, MS, MD, Anna Butusova, MS, Naira Samarina, PhD, Alexandra Boyko, MS, Zhongmin Xiang, PhD, Monique Johnson, BS, Sandrine Degryse, PhD, Florence K. Keane, MD, Lecia V. Sequist, MD, Michael Lanuti, MD, Nathan Fowler, MD, Mari Mino-Kenudson, MD, Alexander Bagaev, PhD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 7, Pp 100527- (2023)
مصطلحات موضوعية: B cells, resected, lung cancer, tumor microenvironment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364323000668Test; https://doaj.org/toc/2666-3643Test
-
3دورية أكاديمية
المؤلفون: Alissa J. Cooper, MD, Alona Muzikansky, MA, Jochen Lennerz, MD, PhD, Farhaana Narinesingh, M.B.B.S., Mari Mino-Kenudson, MD, Yin P. Hung, MD, PhD, Zofia Piotrowska, MD, MHS, Ibiayi Dagogo-Jack, MD, Lecia V. Sequist, MD, MPH, Justin F. Gainor, MD, Jessica J. Lin, MD, Rebecca S. Heist, MD, MPH
المصدر: JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100390- (2022)
مصطلحات موضوعية: Non–small cell lung cancer, KRAS mutation, Targeted therapies, Co-mutations, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S266636432200114XTest; https://doaj.org/toc/2666-3643Test
-
4دورية أكاديمية
المؤلفون: A.J. Piper-Vallillo, MD, Julia K. Rotow, MD, Jacqueline V. Aredo, MD, Khvaramze Shaverdashvili, MD, PhD, Jia Luo, MD, Jennifer W. Carlisle, MD, Hatim Husain, MD, Alona Muzikansky, MA, Rebecca S. Heist, MD, Deepa Rangachari, MD, Suresh S. Ramalingam, MD, Heather A. Wakelee, MD, Helena A. Yu, MD, Lecia V. Sequist, MD, Joshua M. Bauml, MD, Joel W. Neal, MD, PhD, Zofia Piotrowska, MD, MHS
المصدر: JTO Clinical and Research Reports, Vol 3, Iss 6, Pp 100328- (2022)
مصطلحات موضوعية: EGFR, Osimertinib, 160 mg, CNS progression, Leptomeningeal progression, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364322000522Test; https://doaj.org/toc/2666-3643Test
-
5دورية أكاديمية
المؤلفون: Michael Wysota, MD, Saeed Asiry, MD, Yitzhak Goldstein, MD, Lecia V. Sequist, MD, Samer Khader, MD, Balazs Halmos, MD
المصدر: JTO Clinical and Research Reports, Vol 2, Iss 2, Pp 100128- (2021)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S266636432030179XTest; https://doaj.org/toc/2666-3643Test
-
6دورية أكاديمية
المصدر: JACC. CardioOncology, Vol 1, Iss 2, Pp 179-181 (2019)
مصطلحات موضوعية: cardiotoxicity, EGFR, NSCLC, osimertinib, Diseases of the circulatory (Cardiovascular) system, RC666-701, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666087319300973Test; https://doaj.org/toc/2666-0873Test
-
7دورية أكاديمية
المؤلفون: Andrew J. Piper-Vallillo, MD, Meghan J. Mooradian, MD, Catherine B. Meador, MD, PhD, Beow Y. Yeap, ScD, Jennifer Peterson, BS, Mustafa Sakhi, BS, MS, Andrew Do, BS, Leyre Zubiri, MD, Sara Stevens, NP, Jeanne Vaughn, NP, Kelly Goodwin, NP, Alexander Gavralidis, MD, Henning Willers, MD, Adam Miller, MD, Anna Farago, MD, PhD, Zofia Piotrowska, MD, MHS, Jessica J. Lin, MD, Ibiayi Dagogo-Jack, MD, Inga T. Lennes, MD, MPH, MBA, Lecia V. Sequist, MD, MPH, Jennifer S. Temel, MD, Rebecca S. Heist, MD, Subba Digumarthy, MD, Kerry L. Reynolds, MD, Justin F. Gainor, MD
المصدر: JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100124- (2021)
مصطلحات موضوعية: COVID-19, SARS-CoV-2, NSCLC, SCLC, Lung cancer, Thoracic oncology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364320301752Test; https://doaj.org/toc/2666-3643Test
-
8تقرير
المؤلفون: Stanford University, Yale University, University of Maryland, College Park, Genentech, Inc.
المساهمون: Lecia V. Sequist, MD
المصدر: Arvold ND, HearP, KunawudhA, Sequt LV, Mahmood U. Tumor Hypox Response After Targeted Therapy EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMO-PET. Technol Cancer Res Treat. 2016 Apr;15(2):234-42. do 10.1177/1533034615574386. Epub 2015 Mar 10.
Phase II Study of Erlotinib With or Without Hydroxychloroquine in Patients With Previously Untreated Advanced NSCLC and EGFR Mutationsالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00977470Test
-
9تقرير
المؤلفون: University of Texas, Boehringer Ingelheim
المساهمون: Lecia V. Sequist, MD
المصدر: Understanding Mechanisms of Acquired Resistance to BIBW2992
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01074177Test